Skip to main content
. 2018 May 30;12:1525–1531. doi: 10.2147/DDDT.S159818

Figure 3.

Figure 3

Relative risk of carfilzomib-associated (A) all-grade and (B) high-grade CHF in RRMM patients receiving carfilzomib.

Abbreviations: CHF, congestive heart failure; Ctrl, control; Ev, events; RRMM, relapsed and refractory multiple myeloma; Trt, treatment.